Sign in
8-K

Current Report

Niagen Bioscience, Inc. Filed Acc 0001415889-16-006330

Executive or director change · Other events

  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading cdxc8k_june242016.htm…